Analysts Set Revvity, Inc. (NYSE:RVTY) PT at $136.25

Shares of Revvity, Inc. (NYSE:RVTY - Get Free Report) have received a consensus rating of "Moderate Buy" from the thirteen analysts that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokers that have covered the stock in the last year is $136.25.

A number of research analysts recently weighed in on the company. Raymond James reiterated an "outperform" rating and issued a $145.00 target price (up previously from $140.00) on shares of Revvity in a report on Monday, February 3rd. Bank of America raised Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price objective on the stock in a research note on Friday, December 13th. Sanford C. Bernstein downgraded shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 target price for the company. in a research report on Friday, January 10th. Barclays lifted their price target on shares of Revvity from $135.00 to $140.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Finally, KeyCorp boosted their price objective on shares of Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd.

Insider Activity

In related news, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the sale, the insider now directly owns 33,400 shares of the company's stock, valued at $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Tajinder S. Vohra sold 5,492 shares of the firm's stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total transaction of $641,520.52. Following the transaction, the insider now directly owns 19,652 shares of the company's stock, valued at approximately $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.68% of the company's stock.

Remove Ads

Hedge Funds Weigh In On Revvity

Several large investors have recently modified their holdings of the stock. Victory Capital Management Inc. raised its stake in Revvity by 17.4% during the fourth quarter. Victory Capital Management Inc. now owns 70,250 shares of the company's stock valued at $7,841,000 after buying an additional 10,390 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Revvity by 13.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company's stock valued at $43,961,000 after acquiring an additional 41,497 shares during the last quarter. Contravisory Investment Management Inc. raised its position in shares of Revvity by 1,715.9% during the 4th quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company's stock valued at $7,722,000 after acquiring an additional 65,376 shares in the last quarter. FMR LLC lifted its stake in Revvity by 40.8% during the third quarter. FMR LLC now owns 155,556 shares of the company's stock worth $19,872,000 after purchasing an additional 45,040 shares during the last quarter. Finally, Janney Montgomery Scott LLC boosted its holdings in Revvity by 87.0% in the fourth quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock worth $881,000 after purchasing an additional 3,672 shares during the period. Institutional investors own 86.65% of the company's stock.

Revvity Trading Down 5.6 %

Shares of NYSE RVTY traded down $5.96 on Monday, reaching $100.76. 929,332 shares of the company traded hands, compared to its average volume of 877,584. The stock has a market capitalization of $12.11 billion, a PE ratio of 45.59, a P/E/G ratio of 3.82 and a beta of 1.06. Revvity has a fifty-two week low of $97.32 and a fifty-two week high of $129.50. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The company has a 50 day moving average of $113.75 and a 200 day moving average of $116.73.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter last year, the business earned $1.25 earnings per share. On average, equities research analysts forecast that Revvity will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be given a $0.07 dividend. The ex-dividend date is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.28%. Revvity's payout ratio is currently 12.67%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.